Inhalon Biopharma
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 discovery At Ste 220, Morrisville, Nor...Phone Number
(650) 439-0110Website
www.inhalon.comRevenue
$5.5 MillionIndustry
About Inhalon Biopharma
Inhalon Biopharma is a clinical-stage biotechnology company focused on developing an innovative inhaled drug platform for treating acute respiratory infections, including RSV, hMPV, influenza, and SARS-CoV-2. The company aims to enhance treatment effectiveness and convenience for patients through its proprietary inhaled antibody treatments. Inhalon is committed to establishing a simplified test-to-treat model as a new standard in respiratory care. Their target clients include patients suffering from various respiratory infections who seek effective and accessible treatment options.Explore more
SIC Code 28,283NAICS Code 32,325Show moreInhalon Biopharma Org Chart
Compare Similar Companies to Inhalon Biopharma
Compare insights from companies similar to Inhalon Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inhalon Biopharma Tech Stack
A closer look at the technologies used by Inhalon Biopharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inhalon Biopharma
Sign Up For FreeTo access detailed company insights
Inhalon Biopharma is a clinical-stage biotechnology company focused on developing an innovative inhaled drug platform for treating acute respiratory infections, including RSV, hMPV, influenza, and SARS-CoV-2. The company aims to enhance treatment effectiveness and convenience for patients through its proprietary inhaled antibody treatments. Inhalon... Read More